Skip to main content
. 2023 Jan 10;11(1):e04312-22. doi: 10.1128/spectrum.04312-22

TABLE 1.

Comparison of qPCR-positive whole-blood samples to sequencing results from plasma samples

Pathogena No. of samples (mean CT, range) for samples that were positive by qPCR and:
No. of samples negative by qPCR and:
Sequencing vs qPCR sensitivity/specificity
mNGS positive mNGS negative mNGS positive mNGS negative
Viral pathogens          
 CMV 7 (26.8, 21–31.4) 59 (32.3, 20.9–37) 1 187 11%/99%
 Dengue virus 0 5 0 249 0%/100%
 EBV* 3 (21, 17.9–23.3) 107 (35.4, 28.6–39.8) 0 144 3%/100%
 Hepatitis B virus* 14 (15.2, 10.7–22) 28 (32.4, 22.2–35.3) 0 212 33%/100%
 Hepatitis E virus 0 1 1 252 0%/100%
 HIV* 124 (28.3, 21.4–37.3) 52 (32.7, 23–39.2) 6 72 70%/92%
Bacterial pathogens          
S. pneumoniae 1 17 1 235 6%/100%
E. coli 0 4 0 250 0%/100%
Rickettsia spp. 1 5 0 248 17%/100%
P. aeruginosa 0 1 9 244 0%/96%
K. pneumoniae 0 2 0 252 0%/100%
S. aureus 0 2 2 250 0%/99%
Salmonella spp. 0 2 0 252 0%/100%
Leptospira spp. 0 2 0 252 0%/100%
Coxiella spp. 0 1 0 253 0%/100%
M. tuberculosis 1 43 0 207 2%/100%
Other pathogens          
Plasmodium 2 15 0 234 12%/100%
Cryptococcus 0 6 0 248 0%/100%
Toxoplasma 0 2 0 252 0%/100%
a

Asterisks denote pathogens detected by qPCR with plasma sample following sequencing.